Home › Agent Hub › Agent Tools › Part D coverage by drug › Fiasp
Agent Tools
Fiasp is a brand of insulin aspart, human. What agents check before quoting it: how many 2027 Part D plans cover it, on which tier, with what restrictions and copays, by plan type, carrier and state.
In 2027, 4,348 of 5,492 Medicare Part D and Medicare Advantage drug plans (79.2%) list Fiasp on their formulary, across 180 of 286 formularies. The most common placement is tier 3 (4,197 plans, 96.5% of those covering it). 0 of the covering plans require prior authorization (0%), 0 step therapy and 196 a quantity limit. Generic insulin aspart, human is on 5,262 of 5,492 plans (95.8%).
245 covering plans charge a flat copay for a 30-day supply at a preferred retail pharmacy after the deductible — median $37, 69 of them $0; 4,103 charge coinsurance instead — median 20% of the drug's cost. Covered insulin is capped at $35 for a month's supply.
Fiasp has a Medicare negotiated price (maximum fair price) of $119 for a 30-day supply, which applies. The negotiated price lowers what the plan pays; the member's copay or coinsurance still follows the plan's tier.
2026: 5,496 of 5,496 plans covered it (100%); 2027: 4,348 of 5,492 (79.2%).
Of 4,367 plans offered in both years, 0 added it to the formulary and 919 dropped it.
Among plans covering it both years, 30 moved it to a higher tier and 10 to a lower one; 0 added prior authorization and 0 removed it.
| Tier | Plans |
|---|---|
| Tier 1 | 87 |
| Tier 2 | 35 |
| Tier 3 | 4,197 |
| Tier 5 | 10 |
| Tier 6 | 19 |
| Plan type | Plans covering | Share | Prior auth |
|---|---|---|---|
| Stand-alone Part D (PDP) | 241 of 323 | 74.6% | 0% |
| Medicare Advantage with drugs (MA-PD) | 2,480 of 3,200 | 77.5% | 0% |
| Special needs plans (SNP) | 1,627 of 1,969 | 82.6% | 0% |
| Carrier | Plans covering | Usual tier | Prior auth |
|---|---|---|---|
| Humana | 846 of 846 | Tier 3 | 0 |
| UnitedHealthcare | 830 of 830 | Tier 3 | 0 |
| Devoted Health | 728 of 728 | Tier 3 | 0 |
| Aetna Medicare | 631 of 631 | Tier 3 | 0 |
| Wellcare | 0 of 268 | No tier listed | 0 |
| HealthSpring | 226 of 226 | Tier 3 | 0 |
| Kaiser Permanente | 0 of 112 | No tier listed | 0 |
| SCAN Health Plan | 0 of 83 | No tier listed | 0 |
| Highmark Blue Cross Blue Shield or Highmark Blue Shield | 80 of 80 | Tier 3 | 0 |
| Alignment Health Plan | 0 of 77 | No tier listed | 0 |
| Anthem Blue Cross and Blue Shield | 74 of 74 | Tier 3 | 0 |
| Wellpoint | 63 of 63 | Tier 3 | 0 |
| Priority Health Medicare | 0 of 40 | No tier listed | 0 |
| CarePlus Health Plans, Inc. | 37 of 37 | Tier 3 | 0 |
| Zing Health | 36 of 36 | Tier 3 | 0 |
| Capital Blue Cross | 0 of 35 | No tier listed | 0 |
| Prominence Health Plan | 29 of 29 | Tier 3 | 0 |
| Medica | 0 of 27 | No tier listed | 0 |
| Anthem HealthKeepers | 26 of 26 | Tier 3 | 0 |
| Blue Cross Blue Shield of Michigan | 26 of 26 | Tier 3 | 0 |
| State | Plans covering | Share |
|---|---|---|
| Alabama | 107 of 114 | 93.9% |
| Alaska | 7 of 9 | 77.8% |
| American Samoa | 1 of 1 | 100% |
| Arizona | 113 of 147 | 76.9% |
| Arkansas | 74 of 85 | 87.1% |
| California | 198 of 397 | 49.9% |
| Colorado | 93 of 106 | 87.7% |
| Connecticut | 48 of 54 | 88.9% |
| Delaware | 36 of 43 | 83.7% |
| District of Columbia | 9 of 12 | 75% |
| Florida | 443 of 545 | 81.3% |
| Georgia | 123 of 149 | 82.6% |
| Guam | 1 of 1 | 100% |
| Hawaii | 41 of 50 | 82% |
| Idaho | 40 of 45 | 88.9% |
| Illinois | 111 of 132 | 84.1% |
| Indiana | 128 of 138 | 92.8% |
| Iowa | 49 of 64 | 76.6% |
| Kansas | 73 of 84 | 86.9% |
| Kentucky | 110 of 121 | 90.9% |
| Louisiana | 112 of 125 | 89.6% |
| Maine | 46 of 52 | 88.5% |
| Maryland | 37 of 49 | 75.5% |
| Massachusetts | 52 of 89 | 58.4% |
| Michigan | 130 of 182 | 71.4% |
| Minnesota | 23 of 63 | 36.5% |
| Mississippi | 85 of 104 | 81.7% |
| Missouri | 152 of 170 | 89.4% |
| Montana | 24 of 27 | 88.9% |
| Nebraska | 36 of 51 | 70.6% |
| Nevada | 83 of 100 | 83% |
| New Hampshire | 23 of 25 | 92% |
| New Jersey | 55 of 73 | 75.3% |
| New Mexico | 60 of 68 | 88.2% |
| New York | 185 of 215 | 86% |
| North Carolina | 138 of 176 | 78.4% |
| North Dakota | 13 of 26 | 50% |
| Northern Mariana Islands | 1 of 1 | 100% |
| Ohio | 141 of 171 | 82.5% |
| Oklahoma | 79 of 81 | 97.5% |
| Oregon | 68 of 92 | 73.9% |
| Pennsylvania | 226 of 323 | 70% |
| Puerto Rico | 3 of 64 | 4.7% |
| Rhode Island | 22 of 29 | 75.9% |
| South Carolina | 72 of 89 | 80.9% |
| South Dakota | 15 of 30 | 50% |
| Tennessee | 152 of 156 | 97.4% |
| Texas | 355 of 407 | 87.2% |
| U.S. Virgin Islands | 1 of 1 | 100% |
| Utah | 49 of 53 | 92.5% |
| Vermont | 12 of 14 | 85.7% |
| Virginia | 134 of 144 | 93.1% |
| Washington | 84 of 114 | 73.7% |
| West Virginia | 63 of 69 | 91.3% |
| Wisconsin | 71 of 96 | 74% |
| Wyoming | 10 of 13 | 76.9% |
Medicare Part D paid for 755,538 30-day fills of Fiasp in 2024 for about 157,966 enrollees, at an average total cost of $453.99 per 30-day fill (CMS Part D Prescribers by Geography and Drug, national).
Price Fiasp and the rest of a client's list on every plan in their county.
Free tools for licensed insurance agents. Data from CMS public files; verify with plan documents before advising a client.
Counts are over every Medicare Advantage drug plan and stand-alone Part D plan in the CMS monthly formulary files, excluding employer plans. A plan counts as covering a drug when any strength or form of it is on the plan’s formulary; the tier, prior authorization, step therapy and quantity limit shown are the most favorable version on that formulary. Copays are for a 30-day supply at a preferred retail pharmacy after the deductible. This is a reference for licensed agents, not a plan recommendation; verify with the plan’s formulary before advising a client. Source: CMS Part D formulary files (release 10/08/2026). CMS formulary data.